Projects per year
Fingerprint
Dive into the research topics where John W Regan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 2 Finished
Research output
-
The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2
Okura, I., Hasuoka, N., Senoo, K., Suganami, A., Fukushima, K., Regan, J. W., Mashimo, M., Murayama, T., Tamura, Y. & Fujino, H., 2021, (Accepted/In press) In: Pharmacological Reports.Research output: Contribution to journal › Article › peer-review
-
15-Keto-PGE2 acts as a biased/partial agonist to terminate PGE2-evoked signaling
Endo, S., Suganami, A., Fukushima, K., Senoo, K., Araki, Y., Regan, J. W., Mashimo, M., Tamura, Y. & Fujino, H., Sep 18 2020, In: Journal of Biological Chemistry. 295, 38, p. 13338-13352 15 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells
Kurata, N., Tokashiki, N., Fukushima, K., Misao, T., Hasuoka, N., Kitagawa, K., Mashimo, M., Regan, J. W., Murayama, T. & Fujino, H., Jun 15 2019, In: European Journal of Pharmacology. 853, p. 308-315 8 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region
Seira, N., Yamagata, K., Fukushima, K., Araki, Y., Kurata, N., Yanagisawa, N., Mashimo, M., Nakamura, H., Regan, J. W., Murayama, T. & Fujino, H., Dec 2018, In: Pharmacology Research and Perspectives. 6, 6, e00441.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Anti-cancer effects of MW-03, a novel indole compound, by inducing 15-hydroxyprostaglandin dehydrogenase and cellular growth inhibition in the ls174t human colon cancer cell line
Seira, N., Yanagisawa, N., Suganami, A., Honda, T., Wasai, M., Regan, J. W., Fukushima, K., Yamaguchi, N., Tamura, Y., Arai, T., Murayama, T. & Fujino, H., 2017, In: Biological and Pharmaceutical Bulletin. 40, 10, p. 1806-1812 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations